Rezultati pretraživanja
  1. prije 11 sati

    ? 🇧🇪In , the process of enabling , and making available the medicines patients need💊should by law only take up to 40 days from application & investigation to licensing & authorisation, but these deadlines are almost never met? 👇👇

  2. 23. sij

    fosters competition & according to it is the most effective price competition for patented medicines, applying the price differences in different markets often created by the original manufacturer himself.

  3. 21. sij

    Indirect savings in Germany 🇩🇪represent 16.7% of the originators’ revenues, whereas indirect savings in Sweden🇸🇪 represent 12.3% of the market supplied by originators.

  4. has once again acted to the detriment of and systems. also face anticompetitive behaviour every , e.g. unfounded and . Time to act ?

  5. 27. sij

    We believe every EU resident deserves access to the medicine💊they need. helps achieve that. How? By importing surplus medicine from one EU country to relieve shortages in another. Learn more about parallel distribution👇

  6. 3. velj

    helps to ensure the patients in 🇧🇪get the medicine 💊they need, in a more competitive market. 💭Let's talk

  7. play a key role in making medicines more affordable says . We owe it to to listen to those who are in charge of paying for .

  8. 3. velj

    is among the best ways to inject into markets & break down trade barriers. That, in turn, helps to cut medicine costs. If you want to see more competition in the , click the link below & learn more!

  9. We are looking for a colleague to do work. So if you have experience and want to help deliver to EU systems and alleviate of , then here is your chance. Join us!

  10. 27. sij

    ? 🇧🇪 Que la is making efforts by running different programs, at national & local levels, in order to meet the goal of ensuring ✅equal access to care & medicine for every citizen 🇪🇺 is the tool to

  11. 22. sij

    Check out the latest article on the grey market : NOR BLACK NOR WHITE! IT’S GREY. via

  12. 21. sij

    . introducing Przemek Zawadzki from , and Tomasz Dzitko, President of SIRPL (The Polish Parallel Import Association).

  13. 21. sij

    „Zum Wohle der Patienten treten wir in einem sicheren und regulierten Rahmen wirksam gegen die gezielte Kontingentierung von Arzneimitteln durch die Hersteller in den einzelnen Landesmärkten an," sagte Jörg Geller, Präsident von @AffordableMedsEU

  14. 21. sij

    That's some solid numbers to quantify the indirect savings generated by ! Perfect tool to

  15. 21. sij

    Interesting to hear the conclusions of the studies on direct and indirect savings of at the ongoing event!

  16. 21. sij
  17. Welcome to Twitter ! , is a strong player in securing and of in Belgium. Thank you for when occur.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.